Cargando…

Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity

Dendritic cell (DC)-based vaccines are considered useful in cancer immunotherapy, and the interaction of DC and adjuvants is important in the design of the next generation vaccines. In this study, whether DC combined with Rv2299c derived from mycobacteria could improve anti-tumor immune responses in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vo, Manh-Cuong, Lee, Hyun-Ju, Kim, Jong-Seok, Hoang, My-Dung, Choi, Nu-Ri, Rhee, Joon Haeng, Lakshmanan, Vinoth-Kumar, Shin, Sung-Jae, Lee, Je-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741802/ https://www.ncbi.nlm.nih.gov/pubmed/26418952

Ejemplares similares

Sarcoplasmic reticulum Ca(2+) ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells
por: Hong, Cheol Yi, et al.
Publicado: (2016)

Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells
por: Vo, Manh-Cuong, et al.
Publicado: (2017)

Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells
por: Hoang, My-Dung, et al.
Publicado: (2015)

Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic
por: Hoang, My-Dung, et al.
Publicado: (2015)

Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma
por: Vo, Manh-Cuong, et al.
Publicado: (2018)

Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model
por: Vo, Manh-Cuong, et al.
Publicado: (2018)

Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model
por: Vo, Manh-Cuong, et al.
Publicado: (2017)

Natural toll-like receptor agonists in prophylactic vaccines for dendritic cell activation
por: Peng, Paul, et al.
Publicado: (2015)

Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
por: Naumann, Kai, et al.
Publicado: (2013)

A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma
por: Jung, Sung-Hoon, et al.
Publicado: (2017)

A Fusion Protein of Derp2 Allergen and Flagellin Suppresses Experimental Allergic Asthma
por: Tan, Wenzhi, et al.
Publicado: (2018)

Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma
por: Chu, Tan-Huy, et al.
Publicado: (2022)

Activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor CTL responses leading to tumor regression
por: Verma, Vivek, et al.
Publicado: (2016)

Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8(+) T cells
por: Park, Sung Nam, et al.
Publicado: (2013)

Efficiency of Interferon-γ in Activating Dendritic Cells and Its Potential Synergy with Toll-like Receptor Agonists
por: Bian, Yuanzhi, et al.
Publicado: (2023)

Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function
por: Geijtenbeek, Teunis B.H., et al.
Publicado: (2003)

Mycobacteria modulate SUMOylation to suppresses protective responses in dendritic cells
por: Anang, Vandana, et al.
Publicado: (2023)

TLR4, 5, and 9 Agonists Inhibit Murine Airway Invariant Natural Killer T Cells in an IL-12-Dependent Manner
por: Shim, Jae-Uoong, et al.
Publicado: (2012)

Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria
por: Graustein, Andrew D., et al.
Publicado: (2018)

Implication of species change of Nontuberculous Mycobacteria during or after treatment
por: Lee, Jong Sik, et al.
Publicado: (2017)

A stealth adhesion factor contributes to Vibrio vulnificus pathogenicity: Flp pili play roles in host invasion, survival in the blood stream and resistance to complement activation
por: Duong-Nu, Tra-My, et al.
Publicado: (2019)

The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells
por: Guo, Xueheng, et al.
Publicado: (2017)

Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells
por: He, Mi, et al.
Publicado: (2022)

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine
por: Park, Hyun Jin, et al.
Publicado: (2019)

Spotlight on mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge?
por: Mortellaro, Alessandra, et al.
Publicado: (2009)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

Flagellin Modulates the Function of Invariant NKT Cells From Patients With Asthma via Dendritic Cells
por: Shim, Jae-Uoong, et al.
Publicado: (2016)

Correction: Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria
Publicado: (2020)

TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy
por: Gonzalez, Caleb, et al.
Publicado: (2023)

Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists
por: Shey, Muki S., et al.
Publicado: (2016)

Synergy between Vitamin D(3) and Toll-Like Receptor Agonists Regulates Human Dendritic Cell Response during Maturation
por: Brosbøl-Ravnborg, Anne, et al.
Publicado: (2013)

Characterization of the cytokine and maturation responses of pure populations of porcine plasmacytoid dendritic cells to porcine viruses and toll-like receptor agonists
por: Calzada-Nova, Gabriela, et al.
Publicado: (2010)

The Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency
por: Noh, Kyung Tae, et al.
Publicado: (2012)

Is Cross-reactivity with Nontuberculous Mycobacteria a Systematic Problem in the Xpert MTB/RIF Assay?
por: Huh, Hee Jae, et al.
Publicado: (2019)

Vibrio vulnificus RtxA1 Toxin Expression Upon Contact With Host Cells Is RpoS-Dependent
por: Guo, Rui Hong, et al.
Publicado: (2018)

Battery-Free Tattooing Mechanism-Based Functional Active Capsule Endoscopy
por: Hoang, Manh-Cuong, et al.
Publicado: (2022)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Differential modulation of cysteinyl leukotriene receptor 1 and 2 expression by distinct Toll-like receptor agonists in monocyte-derived dendritic cells
por: Rola-Pleszczynski, M, et al.
Publicado: (2004)

Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists
por: Lövgren, Tanja, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i4pfo0ll4k269fjoj0qse5ejgo